HC Surgical Specialists Limited, listed on the Catalist of the Singapore Exchange, has acquired a 51% stake in NYK Endoscopy and Digestive Centre Pte. Ltd. for S$750,000. The acquisition, completed on 8 June 2026, marks a strategic expansion in the company’s endoscopic services, aligning with its focus on general surgery and endoscopy.
NYK Endoscopy, incorporated on 2 June 2026, is set to enhance HC Surgical’s offerings with its provision of endoscopic procedures. The centre will be managed by Dr. Ng Yi Kang, a seasoned gastroenterologist and hepatologist with over 15 years of experience. Dr. Ng, who will oversee operations for at least 11 years, brings expertise in disorders of gut-brain interaction, GERD, and advanced gastrointestinal physiology testing.
Dr. Heah Sieu Min, CEO of HC Surgical, expressed enthusiasm about the acquisition, stating, “We are delighted to welcome Dr. Ng to the Group, as we continue on our expansion in the endoscopic field, to serve the needs of our patients in view of the ageing population in Singapore.”
Dr. Ng also shared his excitement, saying, “I am excited to join HC Surgical Specialists and look forward to contributing to the Group’s commitment towards delivering high-quality, evidence-based and patient-centred care in gastroenterology and digestive health.”
The acquisition will be financed through internal resources and/or bank borrowings. HC Surgical plans to acquire the remaining 49% of NYK Endoscopy at a later date, further solidifying its position in the medical services sector.
